Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1)

Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1)

Item

http://www.wikidata.org/entity/Q36627206

Q36627206

about

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.Vinflunine in the treatment of advanced urothelial cancer: clinical evidence and experience.Emerging drugs for urothelial (bladder) cancer.Immunotherapy in Urothelial Cancer: Recent Results and Future Perspectives.Systemic therapy in muscle-invasive and metastatic bladder cancer: current trends and future promises.Upper tract urothelial carcinoma topical issue 2016: treatment of metastatic cancer.Nivolumab for the treatment of bladder cancer.Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract: an evidence-based review of safety, efficacy, and place in therapy.

P2860

Q30275266-871D45ED-B11B-4020-97C0-E69F13C67809 Q37514607-00EFA92A-83BE-4656-A906-FD92BAD1A1A8 Q38677414-18B35C5C-B8A8-44E6-A604-A4883D7ECCCB Q38685278-6B6C8C15-1C59-4B31-B5E9-0922997D418D Q38852690-0F2452F6-0D0D-4A28-862B-5F4B01C385E8 Q38876486-272943B6-B0A2-4DF5-B426-30C41C75B053 Q39454030-E2CE2696-C923-4203-91E3-4BED9FF82BB2 Q48502786-61211A81-6033-4127-A7FC-1607385A21D9

P2860

Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1)

Item

http://www.wikidata.org/entity/Q36627206

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Vinflunine-gemcitabine versus ...... mized phase II trial (JASINT1)

@ast

Vinflunine-gemcitabine versus ...... mized phase II trial (JASINT1)

@en

type

Item

label

Vinflunine-gemcitabine versus ...... mized phase II trial (JASINT1)

@ast

Vinflunine-gemcitabine versus ...... mized phase II trial (JASINT1)

@en

prefLabel

Vinflunine-gemcitabine versus ...... mized phase II trial (JASINT1)

@ast

Vinflunine-gemcitabine versus ...... mized phase II trial (JASINT1)

@en

P1476

Vinflunine-gemcitabine versus ...... mized phase II trial (JASINT1)

@en

P2093

A Flechon

http://www.w3.org/2001/XMLSchema#string

C Lucas

http://www.w3.org/2001/XMLSchema#string

C-C Lin

http://www.w3.org/2001/XMLSchema#string

E Senkus-Konefka

http://www.w3.org/2001/XMLSchema#string

J Bellmunt

http://www.w3.org/2001/XMLSchema#string

L Albiges

http://www.w3.org/2001/XMLSchema#string

L Mourey

http://www.w3.org/2001/XMLSchema#string

M De Santis

http://www.w3.org/2001/XMLSchema#string

M M Retz

http://www.w3.org/2001/XMLSchema#string

N Vaissière

http://www.w3.org/2001/XMLSchema#string

P2860

Paclitaxel and gemcitabine chemotherapy for advanced transitional-cell carcinoma of the urothelial tract: a phase II trial of the Minnie pearl cancer research network.

The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma. A Phase II study of the Hellenic Cooperative Oncology Group.

Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986

Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tract.

How to manage intravenous vinflunine in cancer patients with renal impairment: results of a pharmacokinetic and tolerability phase I study.

Phase II study of gemcitabine, carboplatin, and bevacizumab in patients with advanced unresectable or metastatic urothelial cancer.

Randomized phase II/III trial assessing gemcitabine/ carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer "unfit" for cisplatin-based chemotherapy: phase II--results of EORTC study 30986.

Treatment of patients with metastatic urothelial cancer "unfit" for Cisplatin-based chemotherapy.

Patient eligibility and trial design for the salvage therapy of advanced urothelial carcinoma.

Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565.

P304

449-454

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDV609

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Andrea Necchi

Wu-Chou Su

Paweł Wiechno

P577

2015-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

287213256

http://www.w3.org/2001/XMLSchema#string

P698

26673352

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial

chemotherapy

P932

4769994

http://www.w3.org/2001/XMLSchema#string

Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1)

about

P2860

P2860

Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1)

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932